Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for
Binge-Eating Disorder
Location: Portland OR, Walnut Creek CA, Encino CA, West Covina CA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase 3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Portland OR, Redding CA, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: Portland OR, Minnetonka MN, Overland Park KS,
Sponsor: Claris Biotherapeutics, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07636590

Recruiting

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

for
Parkinson Disease
Location: Portland OR, Seattle WA, Bellevue WA, Los Angeles CA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 40 - 70+

Code: NCT06976268

Phase 2, Phase 3, Recruiting

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

for
Juvenile Psoriatic Arthritis
Location: Portland OR, Salt Lake City UT, Loma Linda CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 17

Code: NCT06751238

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

for
Systemic Lupus Erythematosus
Location: Portland OR, Vancouver, Salt Lake City UT,
Sponsor: AstraZeneca

Sex: All

Age: 5 - 17

Code: NCT05835310

Phase 3, Recruiting

Connect for Cancer Prevention Study (Connect)

for
Cancer, General Research Use
Location: Portland OR, Denver CO, Sioux Falls SD, Minneapolis MN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70

Code: NCT04609072

Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Portland OR, Abbotsford, Vancouver, Palo Alto CA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase 2, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Portland OR, Eugene OR, Vancouver, Sacramento CA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Portland OR, Eugene OR, Everett WA, Santa Rosa CA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase 1, Phase 2, Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: Portland OR, Eugene OR, Vallejo CA, Edmonton,
Sponsor: Kartos Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT05797831

Phase 2, Phase 3, Recruiting

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Portland OR, Seattle WA, Duarte CA, Goodyear AZ,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07525206

Phase 3, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Portland OR, Los Angeles CA, Fullerton CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase 2, Recruiting

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Portland OR, Eugene OR, Denver CO, Maple Grove MN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07011576

Phase 2, Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Portland OR, Vancouver WA, Seattle WA, Duarte CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase 1, Phase 2, Recruiting

Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices

for
Diabetes, Interleukins, Cytokines
Location: Portland OR
Sponsor: Legacy Health System

Sex: All

Age: 18+

Code: NCT00552942

Phase 3, Recruiting

Supracondylar Pinning Antibiotic Stewardship (SPAS) Trial

for
Supracondylar Humerus Fracture, Infection
Location: Portland OR
Sponsor: Legacy Health System

Sex: All

Age: 0 - 18

Code: NCT04288206

Recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Portland OR, Seattle WA, Boise ID, San Francisco CA,
Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

for
Neuroblastoma
Location: Portland OR, Oakland CA, San Diego CA, Minneapolis MN,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT05489887

Phase 2, Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

for
Neuroblastoma
Location: Portland OR, Dallas TX, Austin TX, St Louis MO,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT06540963

Phase 2, Recruiting